Medscape1d
GLP-1 Reduces Recurrent Ischemic Stroke in Type 2 Diabetes
Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...
Endocrinology Advisor5d
GLP-1 RAs Tied to Higher Thyroid Cancer Risk in First Year of Treatment
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.
Medscape11h
HFpEF and Obesity: Breakthrough Results With GLP-1 Therapies
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
Medical News Today4d
Review links 3 potentially-blinding eye conditions to GLP-1 drugs like Ozempic
A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...
SignalSCV1d
The Santa Clarita Valley Signal | #1 source for breaking and local news
Filled with the top stories to start your day, and emergency news alerts.
eLife4d
Sphingosine-1-phosphate signaling regulates the ability of Müller glia to become neurogenic, proliferating progenitor-like cells
This important study investigates the signaling pathways regulating retinal regeneration. Convincing evidence shows that the sphingosine-1 ... like cells. We thank Dr. Timothy Hla for advice regarding ...